Atovaquone And Proguanil Hydrochloride Tablet, Film Coated
Product Images NDC 51407-869

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hydrochloride (NDC 51407-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquone Structural Formula (039ad3a4 D2db 40c8 Be97 F44218149744 01)

Chemical structure diagram showing the molecular arrangement of the active ingredient atovaquone as part of the drug Atovaquone and Proguanil Hydrochloride.*

FDA Label Image

Proguanil Hydrochloride Structural Formula (039ad3a4 D2db 40c8 Be97 F44218149744 02)

Chemical structure of atovaquone and proguanil hydrochloride showing the molecular arrangement with chlorine, nitrogen, hydrogen atoms, and hydrochloride (HCl) group.*

FDA Label Image

51407-869-01lb (Atovaquone Pronguanil HCI)

Atovaquone and Proguanil Hydrochloride tablets, film-coated, 250 mg/100 mg strength, in a package of 100 tablets. Label includes NDC 51407-869-01, manufacturer GSMS Incorporated, and storage instructions. Warnings about safety seal and child safety are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.